DaVita Celebrates 20 Years on Fortune's List of World's Most Admired Companies

February 26, 2026 9:15 AM

DaVita, a leading provider of comprehensive kidney care, has been named to Fortune's World's Most Admired Companies list for the 20th time, marking two decades of sustained recognition for its commitment to culture, innovation, teammate (employee) well‑being and social responsibility. The milestone reflects DaVita's enduring mission-to be the provider, partner and employer of choice-and highlights how a values‑driven culture can power long‑term...

Read more

Are Young Adults Still Smoking? A CVS Health Survey Unveils Striking Insights

February 26, 2026 9:00 AM

Originally published on CVS Health Company NewsBy Dr. David Fairchild, SVP and Chief Medical Officer, Retail Health, CVS Health®Key pointsThe work to end tobacco and nicotine use in the U.S. is as important as ever - according to findings from a CVS Health® survey.One third of U.S. young adults use nicotine products, and half don't know how to access cessation programs.As electronic cigarettes (e-cigarettes) continue to gain popularity, there is...

Read more

Stemtech Corporation Launches New Market Channel Biosciences Ecommerce

February 26, 2026 8:30 AM

Stemtech Corporation, the global leader and pioneer in stem cell nutrition, launches Stemtech BioSciences E-Commerce Retail market channel.(Stemtech Corporation - OTCID:STEK)"Live Longer - Live Better - Live Younger"President & COO, John W. Meyer stated "We are pleased to launch our new BioSciences Platform. This new program is a powerful initiative designed to expand our reach and to strengthen and diversify our foundation. BioSciences will...

Read more

CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness

February 26, 2026 8:30 AM

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in proven, science-backed natural ingredients and products, today announced the launch of Empowr, a plant-based protein and creatine powder for everyday adults looking to increase daily protein intake for overall wellness. "Empowr" represents a dynamic evolution in functional nutrition," said Joseph Dowling,...

Read more

Black Book Research Releases "France: State of Acute Care EHR and Digital Health 2026"

February 26, 2026 8:15 AM

Black Book Market Research today announced the publication of France: State of Acute Care EHR and Digital Health 2026 a qualitative market report intended to support hospital executives, CIO/DSI leadership, clinical informatics teams, and procurement stakeholders evaluating acute-care DPI/EHR modernization and replacement programs for the 2026-2030 planning horizon.The France edition reviews doctrine-aligned interoperability requirements,...

Read more

Umbrella Labs Announces GLP-3R, The New Research Designation For Retatrutide, To Support High Rigor Tri-Receptor Endocrine Signaling Bench Science

February 26, 2026 7:15 AM

Umbrella Labs today announced an updated research catalog standard that formally presents GLP-3R as the internal research designation for retatrutide, also identified as LY-3437943, supplied as a lyophilized peptide vial for laboratory developmental research use only. This program is designed for laboratories building reproducible tri-receptor signaling studies where naming clarity, lot traceability, and documentation readiness directly impact...

Read more

IRLAB Secures Milestone Payment for First Patient Dosed in Phase Ib Study with IRL757 in Parkinson's Disease

February 26, 2026 6:15 AM

IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company focused on discovering and developing new treatments for Parkinson's disease, today announces that the first patient has been dosed in a Phase Ib study with IRL757 - a potential new treatment for Parkinson's disease-related apathy. This event triggers a USD 3 million milestone payment to IRLAB, payable in instalments in 2026. The study is fully funded by IRLAB's development collaborator,...

Read more

AlzeCure Publishes its Year-End Report for January - December 2025

February 26, 2026 2:25 AM

AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6) today announced that its Year-end report for the period January - December 2025 is now available on the company's website: www.alzecurepharma.com/en/section/investors/financial-reports/"We had a positive and active fourth quarter of 2025. During the quarter, our focus was on preparing the Phase II study in Alzheimer's patients with NeuroRestore ACD856, for which we were awarded a grant of EUR 2.5...

Read more

CORRECTION: Protagonist Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

February 25, 2026 5:15 PM

Protagonist Therapeutics (Nasdaq:PTGX) ("Protagonist" or "the Company") today reported financial results for the fourth quarter and full year ended December 31, 2025 and provided a corporate update."In 2025, Protagonist reached new heights with multiple successful Phase 3 outcomes and two NDA filings of our partnered assets, ICOTYDE and rusfertide," said Dinesh V. Patel, Ph.D., the Company's President and CEO. "We see the next 12 to 24 months as...

Read more

Protagonist Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

February 25, 2026 4:05 PM

Protagonist Therapeutics (Nasdaq:PTGX) ("Protagonist" or "the Company") today reported financial results for the fourth quarter and full year ended December 31, 2025 and provided a corporate update."In 2025, Protagonist reached new heights with multiple successful Phase 3 outcomes and two NDA filings of our partnered assets, ICOTYDE and rusfertide," said Dinesh V. Patel, Ph.D., the Company's President and CEO. "We see the next 12 to 24 months as...

Read more

DirectTrust and CARIN Alliance Announce CARIN-CFA Accreditation Recognized by CMS as Evaluation Pathway for Participation in the Medicare App Library

February 25, 2026 2:45 PM

DirectTrust®, a non-profit healthcare industry alliance focused on furthering trust in health technology and data exchange through standards, accreditation, and other services, and the CARIN Alliance, a multi-stakeholder collaborative dedicated to empowering consumers and their authorized caregivers to easily get, use, and share their digital health information when, where, and how they want to in order to achieve their goals, today announced...

Read more

VRCCO Invests in the Future of Veterinary Medicine Through Education-Driven Innovation

February 25, 2026 2:15 PM

As the veterinary profession faces increasing demands, rapid medical advances, and nationwide workforce shortages, the Veterinary Referral Center of Central Oregon (VRCCO) is taking a proactive approach by strengthening the future of veterinary medicine through continuous education and hands-on professional development.Through expanded learning initiatives including a Virtual Radiation Safety Course, the 2026 Spring Symposium, and robust...

Read more

The National Children's Cancer Society Earns Platinum Seal of Transparency from Candid

February 25, 2026 1:20 PM

The National Children's Cancer Society (NCCS) is proud to announce it has earned the Platinum Seal of Transparency from Candid, the highest level of recognition awarded to nonprofit organizations for openness and accountability.The Platinum Seal of Transparency is granted to organizations that publicly share detailed information about their mission, strategies, capabilities, achievements, and measurable impact. This distinction places the NCCS...

Read more

Lawrence "Larry" Waldman Calls for Stronger Action Against Healthcare Fraud

February 25, 2026 11:45 AM

Lawrence "Larry" Waldman, President of Cyberhealth AI and founder of Ai Health Technologies, Inc., is raising awareness about the growing impact of healthcare provider fraud and the urgent need for better prevention tools across Medicare and commercial insurance systems.Healthcare fraud is a costly and widespread issue in the United States. According to the National Health Care Anti-Fraud Association (NHCAA), healthcare fraud is estimated to...

Read more

Crystal Cove Recovery, a Laguna Beach Addiction Treatment Center, Collaborates with Intervention On Call for Strategic Site Visit

February 25, 2026 11:00 AM

Crystal Cove Recovery, a premier addiction treatment center in Laguna Beach, California, is pleased to announce the successful completion of a collaborative site visit and dinner with Intervention On Call, a national crisis intervention service supporting families and treatment providers navigating complex addiction and mental health cases. The event was designed to strengthen coordination between crisis intervention and residential treatment,...

Read more

Four Borland Groover Ambulatory Surgery Centers Named Among Best ASCs by U.S. News & World Report

February 25, 2026 10:00 AM

U.S. News & World Report has released its inaugural ratings of the nation's top ambulatory surgery centers, naming four Borland Groover facilities among this year's high performers in the colonoscopy and endoscopy category. The recognized centers include Orange Park Endoscopy Center, Jacksonville Center for Endoscopy Riverside, Jacksonville Center for Endoscopy Southside and St. Augustine Endoscopy Center.In 2024, U.S. News launched its...

Read more

CASI Pharmaceuticals Receives the Delisting Decision From the Nasdaq Hearings Panel

February 25, 2026 9:00 AM

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing CID-103, a potential best-in-class, anti-CD38 monoclonal antibody for patients with organ transplant rejection and autoimmune diseases, today announced that it has received a determination letter from the Hearings Panel (the "Panel") of The Nasdaq Stock Market ("Nasdaq") dated February 23, 2026, notifying the Company that the Panel...

Read more

Aspire Biopharma's Buzz Bomb(TM) Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon Sponsorship

February 25, 2026 8:30 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), today announced a massive expansion of its social media and digital marketing footprint for its wholly owned subsidiary, Buzz Bomb Caffeine Company. The initiative follows a successful strategic rebranding and a high-profile sponsorship of professional ultra-marathoner Ashley Paulson, whose recent world-record performance catalyzed a significant increase in brand...

Read more

Duly Surgeon First in Illinois to Use Tumor-Illuminating Technology for Ovarian Cancer Surgery

February 25, 2026 8:00 AM

Duly Health and Care this month announced that Dr. Sameer Sharma, a gynecologic oncologist at Duly Health and Care's Chicagoland med­ical group, DuPage Medical Group, Ltd., is the first physician in Illinois to perform ovarian cancer surgery using Cytalux, a newly approved imaging agent that causes cancerous tissue to "glow" - and can thus help surgeons see and remove tumors with greater precision."Ovarian cancer surgery often comes down to what...

Read more

Burst Raises $3M To Help Retailers Maximize FSA/HSA Spend While Lowering Consumer Health Costs

February 25, 2026 8:00 AM

Burst (formerly Float), the healthcare payments platform that helps retailers and wellness brands unlock billions in untapped FSA and HSA spending, today announced it has raised $3 million in total funding, including a $2.1 million seed round led by Pear VC with participation from Rock Health Capital, Alumni Ventures, and others. The capital will accelerate product development and fuel partnerships with retailers, e-commerce brands, and plan...

Read more